In the UK, a coalition of top industry groups, including the Cannabis Industry Council (CIC), Medical Cannabis Clinicians Society (MCCS), Volteface, and Maple Tree Consultants, launched a new campaign that aims to grant general practitioners (GPs) the authority to prescribe medical cannabis to their patients.
Dubbed the 'Protect our Patients' campaign, it aims to extend the same prescription rights to GPs that consultants have. “The current model for medical cannabis where only consultants can prescribe is simply not working in the interests of the majority of patients,” said Professor Mike Barnes, who founded both the MCCS and CIC.
However, Barnes believes that …